Nutrien Ltd.

TSX:NTR 주식 리포트

시가총액: CA$46.4b

Nutrien 과거 순이익 실적

과거 기준 점검 4/6

Nutrien의 수입은 연평균 -19.2%의 비율로 감소해 온 반면, Chemicals 산업은 수입이 연평균 12.4% 증가했습니다. 매출은 연평균 1.4%의 비율로 감소해 왔습니다. Nutrien의 자기자본이익률은 9.6%이고 순이익률은 8.9%입니다.

핵심 정보

-19.25%

순이익 성장률

-16.39%

주당순이익(EPS) 성장률

Chemicals 산업 성장률4.55%
매출 성장률-1.38%
자기자본이익률9.59%
순이익률8.88%
다음 순이익 업데이트06 Aug 2026

최근 과거 실적 업데이트

Recent updates

내러티브 업데이트 May 20

NTR: Tighter Fertilizer Markets And DOJ Probe Will Guide Future Returns

Analysts have trimmed the fair value estimate for Nutrien to CA$92.08 from CA$95.15, reflecting slightly lower revenue and margin assumptions, even as recent research points to mixed price target changes across the Street. Analyst Commentary Recent Street research presents a mixed picture, with some firms lifting price targets and ratings while others trim expectations or shift to a more cautious stance.
내러티브 업데이트 May 03

NTR: Tighter Fertilizer Markets And DOJ Probe Will Shape Future Returns

The updated analyst price target for Nutrien reflects a small decrease of about CA$0.26. Analysts are balancing slightly softer implied revenue growth and a marginally higher discount rate against firmer profit margin assumptions and a modestly lower future P/E multiple.
내러티브 업데이트 Apr 19

NTR: Tighter Fertilizer Markets And DOJ Probe Will Shape Balanced Outlook

The analyst price target for Nutrien has risen by CA$4.18. Analysts attribute this change to updated assumptions for slightly stronger revenue growth, higher profit margins, and a lower future P/E multiple, reflecting the recent wave of higher sector targets and tighter global fertilizer markets.
내러티브 업데이트 Apr 04

NTR: Tighter Fertilizer Markets And DOJ Probe Will Pressure Future Returns

Analysts have nudged the fair value estimate for Nutrien higher to CA$95.41. This reflects a modestly lower discount rate, slightly firmer long term margin assumptions, and updated sector P/E comparisons that incorporate a wave of recent price target increases tied to tighter fertilizer markets and higher commodity pricing expectations.
내러티브 업데이트 Mar 21

NTR: Higher Fertilizer Pricing And DOJ Probe Will Shape Share Performance

Analysts have lifted the average Nutrien price target by roughly CA$31 to around CA$95, citing stronger fertilizer pricing, higher expected profit margins and support for elevated sector valuation multiples, despite more cautious views on volume growth. Analyst Commentary Recent research on Nutrien largely centers on fertilizer pricing, geopolitical risks and the earnings impact of tighter nitrogen and potash markets.
내러티브 업데이트 Mar 07

NTR: Nutrient Pricing, Portfolio Actions And DOJ Probe Will Shape Balanced Outlook

The analyst price target for Nutrien has increased to CA$101.07 from CA$96.56, as analysts factor in firmer nutrient pricing expectations, potential nitrogen upside tied to recent geopolitical events, and company-specific portfolio actions that they view as supportive of earnings stability and cash generation. Analyst Commentary Recent research points to a broadly constructive tone around Nutrien, with multiple firms updating models after the Q4 report and adjusting price targets on the back of nutrient pricing assumptions, portfolio moves, and expected cash generation.
내러티브 업데이트 Feb 21

NTR: Firmer Nutrient Pricing And Potash Supply Risks Will Shape Balanced Returns

Our updated fair value estimate for Nutrien edges higher to CA$96.56 from CA$91.99, reflecting a series of analyst price target increases tied to refreshed models after recent results, stronger assumed profit margins, and expectations that nutrient pricing holds firmer for longer, even as some remain cautious about future potash supply. Analyst Commentary Street research on Nutrien has been active, with several firms revisiting their models and adjusting price targets around recent and upcoming quarterly results.
내러티브 업데이트 Feb 07

NTR: Reassessed P/E And Farm Headwinds Will Shape Balanced Returns Ahead

Analysts have raised our Nutrien fair value estimate to $91.99 from $88.43, as recent price target increases and rating changes suggest a reassessment of the stock's risk profile, growth outlook, and appropriate future P/E multiple. Analyst Commentary Recent Street research on Nutrien has become more constructive, with several firms increasing price targets or improving ratings while others remain cautious on end market conditions and sector headwinds.
내러티브 업데이트 Jan 23

NTR: Higher Fertilizer Pricing And Buybacks Will Support Future Upside

Our analyst price target for Nutrien edges slightly lower to about $112.49 from $113.03, as analysts weigh mixed sector commentary on fertilizer and agriculture markets against recent target adjustments and an updated future P/E assumption of roughly 20.2x. Analyst Commentary Recent Street research on Nutrien reflects mixed sector views but a generally supportive tone on the company, with several bullish analysts adjusting targets and ratings while acknowledging a more cautious backdrop for fertilizers and agriculture.
내러티브 업데이트 Jan 09

NTR: Fertilizer Cycle Concerns Will Pressure Shares Despite Recent Buybacks

Narrative Update Analysts have nudged their consolidated price target for Nutrien down by about $2 to $64. This reflects updated views that factor in more cautious fertilizer and agriculture setups, modestly lower assumed revenue growth, a slightly higher profit margin profile, and a reduced future P/E multiple in their models.
내러티브 업데이트 Dec 21

NTR Is Expected To Benefit From Potential Upside In Fertilizer Pricing

Analysts have modestly reduced their price target on Nutrien to approximately $113 from about $97, citing a tougher near term backdrop for farmers, slightly lower growth and margin expectations, and a more balanced risk reward profile after the stock's strong run. Analyst Commentary Recent Street research reflects a mixed but generally constructive stance on Nutrien, with several firms trimming price targets modestly while maintaining positive ratings.
내러티브 업데이트 Dec 07

NTR: Portfolio Streamlining And Farm Headwinds Will Shape Balanced Returns Ahead

Analysts have modestly reduced their price expectations for Nutrien, trimming the target by a low single digit dollar amount to reflect a tougher near term farm income backdrop, portfolio streamlining impacts, and a more balanced risk reward view despite solid recent execution. Analyst Commentary Street research on Nutrien reflects a constructive long term view, tempered by nearer term caution around farm fundamentals, commodity pricing and the impact of recent portfolio moves.
내러티브 업데이트 Nov 23

NTR: Portfolio Streamlining And Asset Sales Will Drive Sector Outperformance Ahead

Nutrien's analyst price target has been modestly reduced by $0.21 to $88.43. Analysts cite ongoing sector headwinds, including weaker crop prices, portfolio adjustments, and a more balanced risk-reward outlook, despite solid recent performance.
내러티브 업데이트 Nov 07

NTR: Portfolio Streamlining and Supply Tightness Will Shape Upside Amid Sector Scrutiny

Nutrien’s average analyst price target has edged slightly lower in recent weeks, as analysts weigh a modestly improving profit margin and fair value estimate against easing revenue growth and persistent caution over the agricultural cycle. Analyst Commentary Recent analyst activity around Nutrien highlights both opportunities and challenges for the company as it navigates ongoing market volatility and shifting sector dynamics.
내러티브 업데이트 Oct 24

Shifting Market Trends Will Shape Fertilizer Demand Amid Agricultural Cycle Uncertainty

Nutrien's analyst price targets have recently edged lower by $1 to $2 per share, as analysts cite cautious earnings expectations, a more balanced risk-reward profile, and the impact of portfolio adjustments on future performance. Analyst Commentary Recent Street research highlights a divided outlook among analysts covering Nutrien, reflecting both positive and cautionary perspectives as the company navigates its next phase of growth and portfolio transformation.
내러티브 업데이트 Oct 09

Global Food Demand And Precision Ag Will Secure Fertilizer Success

Analysts have modestly raised their price target for Nutrien, increasing it by approximately $1.38 to reflect updated earnings projections and evolving outlooks for fertilizer market conditions. Analyst Commentary Recent street research reflects a mixed outlook on Nutrien's growth trajectory, valuation, and near-term execution capacity.
분석 기사 Sep 08

With Nutrien Ltd. (TSE:NTR) It Looks Like You'll Get What You Pay For

Nutrien Ltd.'s ( TSE:NTR ) price-to-earnings (or "P/E") ratio of 20.1x might make it look like a sell right now...
분석 기사 Aug 08

Nutrien Ltd. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Shareholders might have noticed that Nutrien Ltd. ( TSE:NTR ) filed its second-quarter result this time last week. The...
분석 기사 Jul 16

Nutrien (TSE:NTR) Has Some Way To Go To Become A Multi-Bagger

What are the early trends we should look for to identify a stock that could multiply in value over the long term? One...
분석 기사 Jul 03

A Look At The Fair Value Of Nutrien Ltd. (TSE:NTR)

Key Insights Using the 2 Stage Free Cash Flow to Equity, Nutrien fair value estimate is CA$98.09 Current share price of...
User avatar
새로운 내러티브 Feb 09

Accelerated Efficiency And Expanded Potash And Nitrogen Output Will Strengthen Future Operations

Accelerated operational efficiency and strategic sales expansion may enhance margins and boost revenue without significant new capital expenditure.

매출 및 비용 세부 내역

Nutrien가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.


순이익 및 매출 추이

TSX:NTR 매출, 비용 및 순이익 (USD Millions)
날짜매출순이익일반관리비연구개발비
31 Mar 2626,8772,3874,2150
31 Dec 2525,9492,2674,0870
30 Sep 2525,6711,8094,0800
30 Jun 2525,0211,3634,0900
31 Mar 2524,7395274,1180
31 Dec 2425,0166744,1210
30 Sep 2425,5567334,2070
30 Jun 2425,8397904,2220
31 Mar 2427,3258454,1180
31 Dec 2328,0821,2584,0940
30 Sep 2329,9672,1983,9490
30 Jun 2332,5833,7003,9590
31 Mar 2335,4666,8533,9920
31 Dec 2237,0127,6604,0500
30 Sep 2236,7927,7494,1800
30 Jun 2234,6126,8894,1010
31 Mar 2229,8684,4044,0150
31 Dec 2126,8613,1533,8260
30 Sep 2123,6422,2683,6630
30 Jun 2121,8619643,5520
31 Mar 2120,5146213,4090
31 Dec 2020,0534593,3240
30 Sep 2019,534953,2130
30 Jun 2019,4708233,0840
31 Mar 2019,7549163,0520
31 Dec 1919,3169923,0280
30 Sep 1919,6711,3362,8890
30 Jun 1919,4491282,9290
31 Mar 1918,862112,9300
31 Dec 1818,772-312,8910
30 Sep 1816,051-4472,2980
30 Jun 1813,3766361,6310
31 Mar 186,489478290
31 Dec 174,0101542330
30 Sep 173,9731962180
30 Jun 173,8932612210
31 Mar 173,8242302330
31 Dec 163,9211992310
30 Sep 164,2394782530
30 Jun 164,6586792460
31 Mar 165,3309752510
31 Dec 155,7911,1152580
30 Sep 156,3031,4762580
30 Jun 156,4021,5112550

양질의 수익: NTR는 고품질 수익을 보유하고 있습니다.

이익 마진 증가: NTR의 현재 순 이익률 (8.9%)은 지난해 (2.1%)보다 높습니다.


잉여현금흐름 대비 순이익 분석


과거 순이익 성장 분석

수익추이: NTR의 수익은 지난 5년 동안 연평균 19.2% 감소했습니다.

성장 가속화: 지난 1년간 NTR 의 수익 증가율(352.9%)은 연간 평균(-19.2%)을 초과합니다.

수익 대 산업: NTR의 지난 1년 수익 증가율(352.9%)은 Chemicals 업계의 0.6%를 상회했습니다.


자기자본이익률

높은 ROE: NTR의 자본 수익률(9.6%)은 낮음으로 평가됩니다.


총자산이익률


투하자본수익률


우수한 과거 실적 기업을 찾아보세요

기업 분석 및 재무 데이터 상태

데이터최종 업데이트 (UTC 시간)
기업 분석2026/05/27 04:16
종가2026/05/27 00:00
수익2026/03/31
연간 수익2025/12/31

데이터 소스

당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.

패키지데이터기간미국 소스 예시 *
기업 재무제표10년
  • 손익계산서
  • 현금흐름표
  • 대차대조표
분석가 컨센서스 추정치+3년
  • 재무 예측
  • 분석가 목표주가
시장 가격30년
  • 주가
  • 배당, 분할 및 기타 조치
지분 구조10년
  • 주요 주주
  • 내부자 거래
경영진10년
  • 리더십 팀
  • 이사회
주요 개발10년
  • 회사 공시

* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.

별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.

분석 모델 및 스노우플레이크

이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드YouTube 튜토리얼도 제공합니다.

Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.

산업 및 섹터 지표

산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.

분석가 소스

Nutrien Ltd.는 52명의 분석가가 다루고 있습니다. 이 중 15명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.

분석가기관
Harriet LiAccountability Research Corporation
Keith CarpenterATB Cormark
Farooq HamedBarclays